ePI on FHIR: Shaping the Future of Global Healthcare – Join Our Virtual Event!
With a focus on driving global collaboration and learning, this virtual event will feature a distinguished panel of speakers from various regions—with emphasis in the Middle East, and Asia—and certainly Europe. Attendees will have the opportunity to hear first-hand from regulators, industry experts, and other key stakeholders on the latest ePI initiatives, lessons learned, and future plans for digital transformation in healthcare through ePI.
EVENT HIGHLIGHTS
WHEN? October 21, 2024
Time:
09:00-11:00 CET | 08:00-10:00 GMT | 10:00-12:00 Jordan | 15:00-17:00 Taiwan | 16:00-18:00 Tokyo
WHERE? Online (via Zoom)
AGENDA & TOPICS
- General introductions and a Summary of key ePI global developments, Rie Matsui, APAC e-labeling EWG leader; Senior Director and Regional Labeling Head for APAC, Pfizer R&D Japan, & Anne Moen, Coordinator, Gravitate Health; Professor, University of Oslo, Norway
- Introduction to Gravitate Health, Giovanna Ferrari, Project Lead, Gravitate Health; Senior Director and Regional Labeling Head, Pfizer
- EMA – a regulators’ perspective (EU) and lessons learned from ePI pilot, Elizabeth Scanlan, ePI Product Owner, European Medicines Agency
- Jordan – a regulators’ perspective (Middle East) and demo of ePI system/app, Mohd. Rabi, IT Specialist, Drug Directorate, JFDA
- Taiwan – a regulator’s perspective (APAC) and future plans for e-labeling introduction, Chi Chung, Section Chief, TFDA
- Compendia – Felleskatalogen’s 20-year journey towards electronic product information (ePI) in Norway, Bente By Jansen, Managing director, Felleskatalogen AS
Panel Discussion & Q&A
The event will conclude with a panel discussion, where attendees can engage with the speakers and ask questions about ePI’s potential in transforming global healthcare systems.
WHY ATTEND?
This event offers a unique opportunity to gain insights into how FHIR ePI is creating a unified international standard, facilitating better access to medicinal product information, and enabling improvements in patient care and safety. The discussions will also address the benefits and challenges of adopting ePI in different regions.
This session is open to all stakeholders across healthcare and regulatory sectors, and it promises to be the first in a series of similar global discussions aimed at fostering collaboration on ePI innovations.
